Furthermore, miR-128, which targets PDGFRA and EGFR [94], is downregulated in GBM relative to low WHO grade glioma [95–99]. EGFR is also targeted by miR-219-5p, which is downregulated in GBM [100, 101]. Here, EGFR is linked to central nervous system cancer.